Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Multi-Center Double-Blind Study of Early Corticosteroid Cessation vs. Long Term Corticosteroid Therapy With Prograf and CellCept in Primary Renal Transplant Patients

NCT00650468 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00650468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00650468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Multi-Center Double-Blind Study of Early Corticosteroid Cessation vs. Long Term Corticosteroid Therapy With Prograf and CellCept in Primary Renal Transplant Patients
Lead sponsor
Astellas Pharma Inc
Phase
Phase 4
Overall status
Completed
Start date
November 30, 1999
Completion date
December 31, 2007
Enrollment
397 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

renal transplantation